www.marijuanamoment.net Open in urlscan Pro
2606:4700:3032::6815:17e7  Public Scan

Form analysis
3 forms found in the DOM

GET https://www.marijuanamoment.net/

<form method="get" id="searchform" action="https://www.marijuanamoment.net/">
  <input type="text" name="s" id="s" value="Search" onfocus="if (this.value == &quot;Search&quot;) { this.value = &quot;&quot;; }" onblur="if (this.value == &quot;&quot;) { this.value = &quot;Search&quot;; }">
  <input type="hidden" id="searchsubmit" value="Search">
</form>

POST

<form id="mc4wp-form-2" class="mc4wp-form mc4wp-form-869" method="post" data-id="869" data-name="Marijuana News In Your Inbox">
  <div class="mc4wp-form-fields">Get our daily newsletter. <p>
      <label>Email address: </label>
      <input type="email" name="EMAIL" placeholder="Your email address" required="">
    </p>
    <p>
      <input type="submit" value="Sign up">
    </p>
  </div><label style="display: none !important;">Leave this field empty if you're human: <input type="text" name="_mc4wp_honeypot" value="" tabindex="-1" autocomplete="off"></label><input type="hidden" name="_mc4wp_timestamp"
    value="1708362715"><input type="hidden" name="_mc4wp_form_id" value="869"><input type="hidden" name="_mc4wp_form_element_id" value="mc4wp-form-2">
  <div class="mc4wp-response"></div>
</form>

POST

<form id="mc4wp-form-3" class="mc4wp-form mc4wp-form-869" method="post" data-id="869" data-name="Marijuana News In Your Inbox">
  <div class="mc4wp-form-fields">Get our daily newsletter. <p>
      <label>Email address: </label>
      <input type="email" name="EMAIL" placeholder="Your email address" required="">
    </p>
    <p>
      <input type="submit" value="Sign up">
    </p>
  </div><label style="display: none !important;">Leave this field empty if you're human: <input type="text" name="_mc4wp_honeypot" value="" tabindex="-1" autocomplete="off"></label><input type="hidden" name="_mc4wp_timestamp"
    value="1708362715"><input type="hidden" name="_mc4wp_form_id" value="869"><input type="hidden" name="_mc4wp_form_element_id" value="mc4wp-form-3">
  <div class="mc4wp-response"></div>
</form>

Text Content

 * Politics
 * Science & Health
 * Culture
 * Business
 * Video
 * Newsletter
   * Subscribe
 * Remove Ads
 * Bill Tracking
   * About
   * Login Instructions
   * All 2024 Cannabis Bills
   * Bill Hearing Calendar
 * About Marijuana Moment
   * Support Marijuana Moment
   * Subscribe To Newsletter

Connect with us
 * 
 * 
 * 


MARIJUANA MOMENT

NEW FDA REPORT HIGHLIGHTS HOW MARIJUANA RESCHEDULING REVIEW ANALYZED CANNABIS
USERS’ SOCIAL MEDIA POSTS


 * Politics
   
    * Hawaii Panel Advances Therapeutic Psilocybin Bill That Would Protect
      Patients From Penalties
   
    * How Virginia’s Competing Marijuana Sales Bills Differ On Licensing,
      Equity, Taxes And More
   
    * New FDA Report Highlights How Marijuana Rescheduling Review Analyzed
      Cannabis Users’ Social Media Posts
   
    * Alabama Medical Marijuana Access Could Take Months, Even After Licensing
      Lawsuits End
   
    * Advice For The Marijuana Movement And Industry From A Retiring Activist
      (Op-Ed)

 * Science & Health
   
    * Marijuana Tax Revenue Should Fund Education And Housing, Not Police And
      Prisons, Voters Say In New Poll
   
    * Federally Funded Researchers Discover Two New Methods Of Distinguishing
      Hemp And Marijuana To Assist Crime Labs
   
    * Search Interest In Delta-8 THC Nearly Twice As High In States Without
      Legal Marijuana, Study Finds
   
    * Psilocybin, LSD And Other Psychedelics Improve Sexual Satisfaction For
      Months After Use, New Study Finds
   
    * New Study Shows How Marijuana Compounds Like Cannabinoids, Terpenes And
      Flavonoids Interact For Medical Benefits

 * Culture
   
    * Rapper Killer Mike Suggests Giving Black People Control Over Marijuana
      Industry As A Form Of Reparations
   
    * Brooklyn Nets And New York Liberty Become First NBA And WNBA Teams To
      Partner With CBD Company
   
    * UFC Warns Fighters To Stop Using Marijuana ‘Immediately’ So They Aren’t
      Punished Under California Athletics Rules
   
    * Treasury Secretary Yellen Says She Over-Prepared For First Time Using
      Marijuana And Jokes That It ‘Always Helps’ With Candy Crush
   
    * NFL Partnering On New Study Using CBD To Treat Pain And Protect From
      Concussions

 * Business
   
    * Missouri Marijuana Company Argues That Workers Are Not Allowed To Unionize
      Due To Federal Law
   
    * Multiple States Across The Country See Record-Breaking Marijuana Sales To
      Close Out 2023
   
    * Massachusetts Sets Marijuana Sales Record In December, With Total
      Purchases In 2023 Reaching $1.8 Billion
   
    * Missouri Sold More Than $1.3 Billion Worth Of Legal Marijuana In 2023,
      State Figures Show
   
    * Michigan Marijuana Sales Surpassed $3 Billion In 2023 As Retailers Smashed
      Monthly Record In December

 * Video
   
    * Hawaii Panel Advances Therapeutic Psilocybin Bill That Would Protect
      Patients From Penalties
   
    * FDA Officials Join Experts To Discuss Psychedelics Research Challenges And
      Promises
   
    * New York Officials Approve Marijuana Home Grow Rules And New Business
      Licenses Amid ‘Rocky Start’ For Legal Market
   
    * Minnesota Republicans Warn Of ‘Blackouts And Brownouts’ From Marijuana
      Cultivation’s Energy Use
   
    * Maryland Senate Committee Approves Bill To Protect Medical Marijuana
      Patients’ Gun Rights Under State Law

 * Newsletter
   
    * VP Harris reaching out to cannabis pardon recipients (Newsletter: February
      19, 2024)
   
    * DOJ’s new marijuana & hemp testing methods (Newsletter: February 16, 2024)
   
    * German legal cannabis vote scheduled (Newsletter: February 15, 2024)
   
    * Cannabis rescheduling won’t violate treaties, memo says (Newsletter:
      February 14, 2024)
   
    * PA has no choice but to legalize cannabis, gov says (Newsletter: February
      13, 2024)
   
   * Subscribe
 * Remove Ads
 * Bill Tracking
   * About
   * Login Instructions
   * All 2024 Cannabis Bills
   * Bill Hearing Calendar
 * About Marijuana Moment
   * Support Marijuana Moment
   * Subscribe To Newsletter




POLITICS


NEW FDA REPORT HIGHLIGHTS HOW MARIJUANA RESCHEDULING REVIEW ANALYZED CANNABIS
USERS’ SOCIAL MEDIA POSTS

Published

4 hours ago

on

February 19, 2024

By

Kyle Jaeger

The Food and Drug Administration (FDA) is highlighting its scientific review
into marijuana that led the agency to recommend rescheduling—a process that
involved a comprehensive analysis of research, as well looking at hundreds of
posts on social media platforms to see how consumers described cannabis’s
therapeutic impact.

In its 2023 fiscal year Drug Safety Priorities report that was published on
Thursday, FDA’s Center for Drug Evaluation and Research (CDER) discussed various
initiatives that it says illustrate “the depth and versatility of drug safety
initiatives across the Center and FDA.” That includes the cannabis analysis it
conducted under a 2022 directive from President Joe Biden.

CDER said its staff “conducted an expansive review of numerous data sources to
inform a scientific and medical assessment called an Eight Factor analysis
(8FA),” and the results “informed FDA’s recommendation to the Drug Enforcement
Administration (DEA) to down-schedule marijuana to Schedule III” from Schedule I
under the Controlled Substances Act.

States That Legalized Marijuana See Massive Reduction in Tobacco Use

States That Legalized Marijuana See Massive Reduction in Tobacco Use
Legalizing marijuana has had a major impact in tobacco consumption. Despite what
many experts thought, a new study published in the Journal of Health Economics
concluded that state-level cannabis reforms are mostly associated with “small,
occasionally significant longer-run declines in adult tobacco use.” Veuer’s
Maria Mercedes Galuppo has the story.
More Videos


0 seconds of 43 secondsVolume 0%

Press shift question mark to access a list of keyboard shortcuts
Keyboard ShortcutsEnabledDisabled
Play/PauseSPACE
Increase Volume↑
Decrease Volume↓
Seek Forward→
Seek Backward←
Captions On/Offc
Fullscreen/Exit Fullscreenf
Mute/Unmutem
Decrease Caption Size-
Increase Caption Size+ or =
Seek %0-9

Next Up
A New Poll Finds That Floridians Want Legal Marijuana
00:46
facebook twitter Email pinterest
Linkhttps://cdn.jwplayer.com/previews/mNgCnpyB
Copied
Live
00:00
01:48
00:43








 

“As part of CDER’s cross-center evaluation of marijuana, the CDER Office of
Surveillance and Epidemiology (OSE) completed a review of epidemiologic and
pharmacovigilance data sources to inform the 8FA provided to DEA,” it said.

After the conclusion of the FDA review, the U.S. Department of Health and Human
Services (HHS) submitted a letter with hundreds of pages of research material to
DEA with the Schedule III recommendation. DEA is now carrying out its own review
before making a final determination. There were rumors that the decision would
be announced two weeks ago, but a Biden administration official told Marijuana
Moment said they’d “wave off” that speculation.



FDA’s work to reach a scheduling conclusion also involved a team of social
scientists who spent six months conducting a “detailed qualitative analysis of
online and social media conversations occurring about marijuana,” the report
says.

“This six-month study involved manually analyzing hundreds of posts on publicly
available online/social media platforms to provide context directly from users
regarding marijuana, including its effectiveness for several therapeutic
purposes such as anorexia, anxiety, nausea, and pain; nonmedical purposes;
benefits and negative effects, experiences with access,” it says.



Separately, the new FDA report said the agency “completed an assessment of the
capabilities and usefulness of a variety of epidemiologic, pharmacovigilance,
and drug utilization data sources for monitoring the safety of unapproved
cannabis-derived products.”

It’s been nearly six months since FDA provided DEA with is marijuana
rescheduling recommendation, but the timing of a final decision is uncertain. In
the interim, Congressional Cannabis Caucus founder Rep. Earl Blumenauer (D-OR)
recently urged the agency to release more information about its ongoing
review—including what its “planned deadline” is for finishing and whether it
will take into account the fact that many states have already legalized
cannabis.

The correspondence came in response to a recent assertion from DEA that it has
“final authority” on the rescheduling decision—which itself was a reply to
a separate letter from Blumenauer and 30 other bipartisan lawmakers.



On the other side of the issue, a Republican congressman who has long opposed
marijuana reform claimed in a letter to DEA that FDA came to a “misguided
conclusion” to recommend rescheduling cannabis, challenging the health agency’s
scientific standards and imploring DEA to dismiss them as it prepares to make a
final determination.

A separate letter sent to DEA Administrator Anne Milgram this month—led by Sens.
Elizabeth Warren (D-MA) and John Fetterman (D-PA), along with Senate Majority
Leader Chuck Schumer (D-NY) and other champions of marijuana reform—urged DEA to
go further than rescheduling by fully removing cannabis from the CSA.



Meanwhile, HHS Secretary Xavier Becerra said last month that his agency
has “communicated” its “position” on marijuana rescheduling to DEA and has
continued to offer additional information to assist with the final
determination.

Prior to HHS releasing a trove of documents concerning its cannabis
recommendation, a coalition of 12 Democratic state attorneys general implored
DEA to move forward with federal marijuana rescheduling, calling the policy
change a “public safety imperative.”

In another letter in December, 29 former U.S. attorneys called on the Biden
administration to leave cannabis in Schedule I.

Also that month, the governors of six U.S. states—Colorado, Illinois, New York,
New Jersey, Maryland and Louisiana—sent a letter to Biden calling on the
administration to reschedule marijuana by the end of last year.



Meanwhile, six former DEA heads and five former White House drug czars sent a
letter to the attorney general and current DEA administrator voicing opposition
to the top federal health agency’s recommendation to reschedule marijuana. They
also made a questionable claim about the relationship between drug schedules and
criminal penalties in a way that could exaggerate the potential impact of the
incremental reform.

Signatories include DEA and Office of National Drug Control Policy heads under
multiple administrations led by presidents of both major parties.



A coalition of 14 Republican congressional lawmakers, meanwhile,
separately urged DEA to “reject” the top federal health agency’s recommendation
to reschedule marijuana and instead keep it in the most restrictive category
under the CSA.

A recent poll found that about one-third of marijuana consumers say they would
go back to the illicit market if cannabis was rescheduled and only made legally
available as an FDA-approved prescription drug.

Another recent survey found that President Joe Biden stands to make significant
political gains if marijuana is rescheduled under his administrative directive.
Of course, Biden doesn’t directly control the final outcome.

The president has routinely touted his 2022 scheduling directive, as well as a
mass pardon he granted for people who’ve committed federal marijuana possession
offenses. He followed up on that action in December with a renewed and expanded
pardon proclamation. The Justice Department has already begun issuing
certifications for people who applied under the second round.



Vice President Kamala Harris’s office has been reaching out to people who’ve
received a cannabis pardon—seeking assurance that the Justice Department
certification process is going smoothly and engaging in broader discussions
about cannabis policy reform, according to a pardon recipient who was contacted.

> FDA Officials Join Experts To Discuss Psychedelics Research Challenges And
> Promises



Marijuana Moment is made possible with support from readers. If you rely on our
cannabis advocacy journalism to stay informed, please consider a monthly Patreon
pledge.

Related Topics:featured

Up Next

How Virginia’s Competing Marijuana Sales Bills Differ On Licensing, Equity,
Taxes And More

Don't Miss

Alabama Medical Marijuana Access Could Take Months, Even After Licensing
Lawsuits End

Kyle Jaeger


Kyle Jaeger is Marijuana Moment's Sacramento-based managing editor. His work has
also appeared in High Times, VICE and attn.



YOU MAY LIKE

Hawaii Panel Advances Therapeutic Psilocybin Bill That Would Protect Patients
From Penalties

How Virginia’s Competing Marijuana Sales Bills Differ On Licensing, Equity,
Taxes And More

VP Harris reaching out to cannabis pardon recipients (Newsletter: February 19,
2024)

Alabama Medical Marijuana Access Could Take Months, Even After Licensing
Lawsuits End

Advice For The Marijuana Movement And Industry From A Retiring Activist (Op-Ed)

FDA Officials Join Experts To Discuss Psychedelics Research Challenges And
Promises


Advertisement

MARIJUANA NEWS IN YOUR INBOX

Get our daily newsletter.

Email address:



Leave this field empty if you're human:



SUPPORT MARIJUANA MOMENT






 * 
 * 
 * 

 * About Marijuana Moment
 * Subscribe
 * Sponsorship and Advertising
 * Privacy Policy

All the cannabis news you need, all in one place. Copyright © 2017-2024
Marijuana Moment LLC ® and Tom Angell

Information from your device can be used to personalize your ad experience.

Do not sell or share my personal information.
A Raptive Partner Site




MARIJUANA NEWS IN YOUR INBOX

 

Get our daily newsletter.

Email address:



Leave this field empty if you're human:





✕
Do not sell or share my personal information.
You have chosen to opt-out of the sale or sharing of your information from this
site and any of its affiliates. To opt back in please click the "Customize my ad
experience" link.

This site collects information through the use of cookies and other tracking
tools. Cookies and these tools do not contain any information that personally
identifies a user, but personal information that would be stored about you may
be linked to the information stored in and obtained from them. This information
would be used and shared for Analytics, Ad Serving, Interest Based Advertising,
among other purposes.

For more information please visit this site's Privacy Policy.
CANCEL
CONTINUE